United Services Automobile Association Aerie Pharmaceuticals Inc Transaction History

United Services Automobile Association

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$18.41 - $28.0 $1.06 Million - $1.62 Million	-57,682 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$28.97 - $48.21 $590,988 - $983,484	20,400 Added 54.72%	57,682 $1.71 Million
Q1 2019 May 13, 2019	SELL	$36.32 - $49.25 $944,320 - $1.28 Million	-26,000 Reduced 41.09%	37,282 $1.77 Million
Q4 2018 Feb 13, 2019	BUY	$33.0 - $60.04 $1.89 Million - $3.44 Million	57,300 Added 957.87%	63,282 $2.28 Million
Q3 2018 Nov 13, 2018	SELL	$56.15 - $73.9 $35,823 - $47,148	-638 Reduced 9.64%	5,982 $368,000
Q2 2018 Sep 27, 2018	SELL	$47.85 - $70.45 $2.97 Million - $4.38 Million	-62,159 Reduced 90.37%	6,620 $447,000
Q2 2018 Aug 10, 2018	BUY	$47.85 - $70.45 $3.02 Million - $4.44 Million	63,013 Added 1092.84%	68,779 $4.39 Million
Q1 2018 May 14, 2018	BUY	$51.15 - $61.0 $294,930 - $351,726	5,766 New	5,766 $313,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.